| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Country's Decision or any other Communication
Record information and status
Record ID
116216
Status
Published
Date of creation
2021-06-23 11:20 UTC (jnjagi@biosafetykenya.go.ke)
Date of publication
2021-07-09 07:29 UTC (jmuchiri@biosafetykenya.go.ke)

General information
Country submitting the decision or communication
  • Kenya
Competent National Authority(ies) responsible for the decision or communication
National Biosafety Authority
NACOSTI Building, Loresho, off Waiyaki Way
Nairobi, Nairobi
Kenya, 28251--00100
Phone:(+254) (20) (2678667)
Email:info@biosafetykenya.go.ke
Url:National Biosafety Office - Kenya
Title / Reference number of the decision or communication
Application to conduct contained use activity involving confined field trials of transgenic sorghum containing provitamin A and enhanced iron and zinc bio-availability at KALRO Kiboko.
Date of the decision
2015-03-04
Is the decision taken prior to entry into force of the Protocol?
No
Is this an amendment to a previous decision / communication?
No
Decision or communication details
Subject(s) of the decision
  • Decision on LMOs for intentional introduction into the environment (according to Article 10 or domestic regulatory framework)
Was the decision triggered by a request for a transboundary movement of LMOs into the country?
No
Does the decision apply to transboundary movements of LMO(s) into the country?
No
Importer’s or Applicant’s contact details
Dr. Eliud K. Kireger
Director General
Kenya Agricultural & Livestock Research Organisation (KALRO)
Nairobi
Kenya
Phone:+254 418330120
Email:directorgeneral@kalro.org
Result of the decision
  • Approval of the import and/or use of the LMO(s) with conditions
Conditions
The approval was granted to conduct confined field trials only.
Reasons
This is a contained use application
Does the decision involve field trials?
Yes
Does the decision involve commercial release?
No
LMO identification
Sorghum with modified levels of vitamin A, zinc and iron
Changes in quality and/or metabolite content - Vitamins Mannose tolerance Selectable marker genes and reporter genes
Risk assessment
Summary risk assessment report on the application to conduct Confined Field Trials of transgenic Sorghum containing pro-vitamin A and enhanced Iron and Zinc bio-availability.
Sorghum with modified levels of vitamin A, zinc and iron
Changes in quality and/or metabolite content - Vitamins
Mannose tolerance
Selectable marker genes and reporter genes
Decision document